Glycine prevents the induction of apoptosis attributed to mesenteric ischemia/reperfusion injury in a rat model

Surgery

Volumn 134, Issue 3, 2003, Pages 457-466

  Jacob, Theresa ^a   Ascher, Enrico ^a   Hingorani, Anil ^a   Kallakuri, Sreedhar ^a  

^a MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; FAS ANTIGEN; GLYCINE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; RECEPTOR; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOWN REGULATION; DRUG DOSAGE FORM; DRUG MECHANISM; ENZYME SUBSTRATE; EXPERIMENT; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFUSION; INTESTINE ISCHEMIA; MALE; MESENTERY DISEASE; MOLECULAR MECHANICS; MORPHOMETRICS; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PARAMETER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SMALL INTESTINE; STATISTICAL SIGNIFICANCE; TISSUE PRESERVATION;

EID: 0141593476     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0039-6060(03)00164-8     Document Type: Article

References (47)

1. Mustafa NA, Yandi M, Albayrak L, Yildiz K. Effect of pentoxifylline on the ischemia-reperfusion injury of the intestine. Int Surg 1995;80:152-5.
2. Gangadharan SP, Wagner RJ, Cronenwett JL. Effect of intravenous glucagon on intestinal viability after segmental mesenteric ischemia. J Vasc Surg 1995;21:900-7.
3. Kazmers A, Zwolak R, Appelman HD, Whitehouse WM Jr, Wu SC, Zelenock GB, et al. Pharmacologic interventions in acute mesenteric ischemia: improved survival with intravenous glucagon, methylprednisolone, and prostacyclin. J Vasc Surg 1984;1:472-81.
4. Morris JB, Guerrero NH, Furth EE, Stellato TA. Somatostatin attenuates ischemic intestinal iniury. Am J Surg 1993;165:676-80.
5. Kallakuri S, Ascher E, Pagala M, Gade P, Hingorani A, Scheinman M, et al. Protective effect of glycine in mesenteric ischemia and reperfusion injury in a rat model. J Vas Surg. In press.
6. Weinberg JM, Davis JA, Abarzua M, Kiani T, Kunkel R. Protection by glycine of proximal tubules from injury due to inhibition of mitochrondrial ATP production. Am J Physiol 1990;258:C1127-40.
7. Weinberg JM, Davis JA, Abarzua M, Kiani T. Relationship between cell adenosine triphosphate and glutathione content and protection by glycine against hypoxic proximal tubule cell injury. J Lab Clin Med 1989;113:612-22.
8. Ghong Z, Tones S, Thurman RG. Glycine minimizes reperfusion injury in a low flow, reflow liver perfusion model in the rat. Am J Physiol 1996;270:G332-8.
9. Mangino JE, Kotadia B, Mangino MJ. Characterization of hypothermic intestinal ischemia-reperfusion injury in dogs. Effects of glycine. Transplantation 1996;62:173-8.
10. Lee MA, McCauley RD, Kong SE, Hall JC. Infuence of glycine on intestinal ischemia-reperfusion injury. JPEN J Parenter Enteral Nutr 2002;26:130-5.
11. Ascher E, Hanson JN, Cheng W, Hingorani A, Scheinman M. Glycine preserves function and decreases necrosis in skeletal muscle undergoing ischemia and reperfusion injury. Surgery 2001;129:231-5.
12. Shah KA, Shurey S, Green CJ. Apoptosis after intestinal ischemia-reperfusion injury: a morphological study. Transplantation 1997;64:1393-7.
13. Shah KA, Shurey S, Green CJ. Characterization of apoptosis in intestinal ischaemia-reperfusion injury - a light and electron microscopic study. Int J Exp Pathol 1997;78:355-63.
14. Kuenzler KA, Pearson PY, Schwartz MZ. IL-11 pretreatment reduces cell death after intestinal ischemia-reperfusion. J Surg Res 2002;108:268-72.
15. Earnshaw WC. Nuclear changes in apoptosis. Curr Opin Cell Biol 1995;7:337-43.
16. Miller DK. The role of caspase family of endoproteases in apoptosis. Semin Immunol 1997;9:35-49.
17. Kumar S. ICE-like proteases in apoptosis. Trends Biochem Sci 1995;20:198-202.
18. Guide for the Care and Use of Laboratory Animals, Publication No. 85-23. Bethesda: National Institutes of Health, 1985.
19. Oldham KT, Guice KS, Gore D, Gourley WK, Lobe TE. Treatment of intestinal ischemia with oxygenated perfluorocarbons. Am J Surg 1987;153:291-4.
20. Chiu CJ, McArdle AH, Brown R, Scott HJ, Gurd FN. Intestinal mucosal lesion in low flow states: a morphological, hemodynamic and metabolic reappraisal. Arch Surg 1970;101:478-83.
21. Jacob T, Ascher E, Hingorani A, Khandros Y, Zeien L, Tsemekhin B. Differential proteolytic activity and apoptosis in fibrous versus atheromatous plaques in carotid atherosclerotic disease. J Vasc Surg 2001;33:614-20.
22. Scheinman M, Ascher E, Kallakuri S, Hingorani A, Gade P, Sherman M, et al. P53 gene transfer to the injured rat carotid artery promotes apoptosis. Surgery 1999;126:863-8.
23. Li Y, Sharov VG, Jiang N, Zaloga C, Sabbah HN, Chopp M. Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat. Am J Pathol 1995;146:1045-51.
24. Nagatomi A, Sakadia I, Matsumura Y, Okita K. Cytoprotection by glycine against against hypoxia induced injury in cultured hepatocytes. Liver 1997;17:57-62.
25. Tripathi Y, Hegde BM, Rai YS, Raghuveer CV. Effect of N-2-mercaptopropionylgiycine in limiting myocardial reperfusion injury following 90 minutes of ischemia in dogs. Indian J Physiol Pharmacol 2000;44:290-6.
26. Iijima S, Shou J, Naama II, Calvano SE, Daly JM. Beneficial effect of enteral glycine in intestinal ischemia/reperfusion injury. J Gastrointest Surg 1997;1:53-60.
27. Farber A, Connors JP, Friedlander RM, Wagner RJ, Powell RJ, Cronenwett JL. A specific inhibitor of apoptosis decreases tissue injury after intestinal ischemia-reperfusion in mice. J Vasc Surg 1999;30:752-60.
28. Saikumar P, Dong Z, Weinberg JM, Venkatachalam MA. Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 1998;17:3341-9.
29. Panes J, Granger DN. Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 1998;114:1066-90.
30. Satoh MS, Lindahl T. Role of poly(ADP-ribose) formation in DNA repair. Nature 1992;356:356-8.
31. Tewari M, Quan LT, ORourke K, Desnoyers S, Zeng Z, Beidler DR, et al. Yama/CPP32ß, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 1995;81:801-9.
32. Halmosi R, Berente Z, Osz E, Toth K, Literati-Nagy P, Sumegi B. Effect of poly(ADP-ribose) polymerase inhibitors on the ischemia-reperfusion-induced oxidative cell damage and mitochondrial metabolism in Langendorff heart perfusion system. Mol Pharmacol 2001;59:1497-505.
33. Jeremias I, Kupatt C, Martin-Villalba A, Habazettl H, Schenkel J, et al. Involvement of CD95/Apo1/Fas in cell death after myocardial ischemia. Circulation 2000;102:915-20.
34. Pastorino JG, Chen ST, Tafani M, Snyder JW, Farber JL. The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J Biol Chem 1998;273:7770-5.
35. Kluck RM, Bossy-Wetzel E, Green DR, Newmeyer DD. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 1997;275:1132-6.
36. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, et al. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997;275:1129-32.
37. Zhang Y, Ikejima K, Honda H, Kitamura T, Takei Y, Sato N. Glycine prevents apoptosis of rat sinusoidal endothelial cells caused by deprivation of vascular endothelial growth factor. Hepatology 2000;32:542-6.
38. Wheeler M, Stachlewitz RF, Yamashina S, Ikejima K, Morrow AL, Thurman RGJ. Glycine-gated chloride channels in neutrophils attenuate calcium influx and superoxide production. Gastrointest Surg 1997;1:53-60.
39. Froh M, Thurman RG, Wheeler MD. Molecular evidence for a glycine-gated chloride channel in macrophages and leukocytes. Am J Physiol Gastrointest Liver Physiol 2002;283:G856-63.
40. Qu W, Ikejima K, Zhong Z, Waalkes MP, Thurman RG. Glycine blocks the increase in intracellular free Ca2+ due to vasoactive mediators in hepatic parenchymal cells. Am J Physiol Gastrointest Liver Physiol 2002;283:G1249-56.
41. Yao Y, Yu Y, Wu Y, Shi Z, Sheng Z. The role of gut as a cytokine-generating organ in remote organ dysfunction after intestinal ischemia and reperfusion. Chin Med J (Engl) 1998;111:514-8.
42. Hierholzer C, Kalff JC, Audolfsson G, Billiar TR, Tweardy DJ, Bauer AJ. Molecular and functional contractile sequelae of rat intestinal ischemia/reperfusion injury. Transplantation 1999;68:1244-54.
43. Korthuis RJ, Gute DC, Blecha F, Ross CR. PR-39, a proline/arginine-rich antimicrobial peptide, prevents postischemic microvascular dysfunction. Am J Physiol 1999;277:H1007-13.
44. Stachlewitz RF, Li X, Smith S, Bunzendahl H, Graves LM, Thurman RG. Glycine inhibits growth of T lymphocytes by an IL-2-independent mechanism. J Immunol 2000;164:176-82.
45. Yin M, Rusyn I, Schoonhoven R, Graves LM, Rusyn EV, Li X, et al. Inhibition of chronic rejection of aortic allografts by dietary glycine. Transplantation 2000;69:773-80.
46. Wheeler MD, Ikejema K, Enomoto N, Stacklewitz RF, Seabra V, Zhong Z, et al. Glycine: a new antiinflammatory immunonutrient. Cell Mol Life Sci 1999;56:843-56.
47. Ikejima K, Qu W, Stachlewitz RF, Thurman RG. Kupffer cells contain a glycine-gated chloride channel. Am J Physiol 1997;272(6 Pt 1):G1581-6.